One study showed an enhancement of pro‐inflammatory monocyte and anti‐inflammatory T‐cell forces in BD patients,14 while another study reported that compared to healthy controls, BD patients presented an increased circulating proportion of monocytes (CD14+) and a lower proportion of T‐cell (CD3+) and cytotoxic T cells (CD3 + CD8+),15 which was consistent with our previous findings.16 The gene discussed is CD14; the disease is Behcet disease.